The Wockhardt Group, previously a prominent player in the pharmaceutical industry, is facing financial challenges. With mounting debts and a struggling business, the group's substantial assets are now being put up for grabs. This sudden shift in fortunes has sent shockwaves through the industry, spurring speculation within financial circles. It re… Read More